JP2014530200A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530200A5 JP2014530200A5 JP2014531340A JP2014531340A JP2014530200A5 JP 2014530200 A5 JP2014530200 A5 JP 2014530200A5 JP 2014531340 A JP2014531340 A JP 2014531340A JP 2014531340 A JP2014531340 A JP 2014531340A JP 2014530200 A5 JP2014530200 A5 JP 2014530200A5
- Authority
- JP
- Japan
- Prior art keywords
- compounds
- pharmaceutical composition
- compound
- composition according
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 25
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 5
- 208000019022 Mood disease Diseases 0.000 claims 4
- 229920001515 polyalkylene glycol Polymers 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 208000019901 Anxiety disease Diseases 0.000 claims 3
- 230000036506 anxiety Effects 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 2
- 208000017194 Affective disease Diseases 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1116335.9A GB201116335D0 (en) | 2011-09-21 | 2011-09-21 | A method of treating or preventing affective disorders |
| GB1116335.9 | 2011-09-21 | ||
| PCT/IB2012/054700 WO2013042005A1 (en) | 2011-09-21 | 2012-09-10 | N- substituted benzenepropanamide and benzenepropenamide for use in the prevention or the treatment of affective disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530200A JP2014530200A (ja) | 2014-11-17 |
| JP2014530200A5 true JP2014530200A5 (enExample) | 2015-11-05 |
| JP6067022B2 JP6067022B2 (ja) | 2017-01-25 |
Family
ID=44937647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014531340A Expired - Fee Related JP6067022B2 (ja) | 2011-09-21 | 2012-09-10 | 情動障害の予防又は治療に用いるためのｎ−置換ベンゼンプロパンアミド又はベンゼンプロペンアミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9133103B2 (enExample) |
| EP (1) | EP2758046B1 (enExample) |
| JP (1) | JP6067022B2 (enExample) |
| CN (1) | CN103826622B (enExample) |
| AU (1) | AU2012311183B2 (enExample) |
| CA (1) | CA2849055C (enExample) |
| DK (1) | DK2758046T3 (enExample) |
| ES (1) | ES2559294T3 (enExample) |
| GB (1) | GB201116335D0 (enExample) |
| IL (1) | IL231609A (enExample) |
| WO (1) | WO2013042005A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173813A1 (en) * | 2014-05-14 | 2015-11-19 | Novaremed Ltd. | Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes |
| CN107011313B (zh) | 2016-01-27 | 2021-11-30 | 天士力医药集团股份有限公司 | 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用 |
| EP3939578A1 (en) * | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1546088E (pt) * | 2002-10-03 | 2015-03-16 | Novaremed Ltd | Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados |
| US7674829B2 (en) * | 2004-03-26 | 2010-03-09 | Novaremed Limited | Compounds for the treatment of AIDS and other viral diseases |
| WO2005110987A1 (en) | 2004-05-12 | 2005-11-24 | Pfizer Products Inc. | Piperidine derivatives as nk1 and nk3 antagonists |
| RU2309144C2 (ru) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
| GB0804213D0 (en) * | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| PL2475361T3 (pl) * | 2009-09-09 | 2020-07-13 | Novaremed Ltd. | N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego |
-
2011
- 2011-09-21 GB GBGB1116335.9A patent/GB201116335D0/en not_active Ceased
-
2012
- 2012-09-10 CN CN201280045760.3A patent/CN103826622B/zh not_active Expired - Fee Related
- 2012-09-10 WO PCT/IB2012/054700 patent/WO2013042005A1/en not_active Ceased
- 2012-09-10 EP EP12780536.4A patent/EP2758046B1/en not_active Not-in-force
- 2012-09-10 DK DK12780536.4T patent/DK2758046T3/da active
- 2012-09-10 ES ES12780536.4T patent/ES2559294T3/es active Active
- 2012-09-10 AU AU2012311183A patent/AU2012311183B2/en not_active Ceased
- 2012-09-10 US US14/346,419 patent/US9133103B2/en not_active Expired - Fee Related
- 2012-09-10 JP JP2014531340A patent/JP6067022B2/ja not_active Expired - Fee Related
- 2012-09-10 CA CA2849055A patent/CA2849055C/en not_active Expired - Fee Related
-
2014
- 2014-03-19 IL IL231609A patent/IL231609A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009536191A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2011173928A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| IL314360A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
| JP2009102342A5 (enExample) | ||
| JP2013519632A5 (enExample) | ||
| JP2014518266A5 (enExample) | ||
| JP2008539267A5 (enExample) | ||
| JP2013507415A5 (enExample) | ||
| JP2008539268A5 (enExample) | ||
| JP2011102304A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2012072150A5 (enExample) | ||
| JP2013511496A5 (enExample) | ||
| JP2015505296A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2014507477A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2012530779A5 (enExample) | ||
| NZ703564A (en) | Oral formulations and lipophilic salts of methylnaltrexone | |
| JP2014505017A5 (enExample) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| RU2015149527A (ru) | Производные доластатина 10 и ауристатинов | |
| JP2011513377A5 (enExample) |